EP0385491 - Optically active isomer of cloperastine possessing antitussive activity, a process for its preparation and pharmaceutical compositions which contain it [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 07.11.1995 Database last updated on 30.10.2024 | Most recent event Tooltip | 07.11.1995 | Application deemed to be withdrawn | published on 27.12.1995 [1995/52] | Applicant(s) | For all designated states MAGIS FARMACEUTICI S.P.A. Via Cacciamali 34/36/38 I-25125 Brescia / IT | [N/P] |
Former [1990/36] | For all designated states MAGIS FARMACEUTICI S.p.A. Via Cacciamali 34/36/38 I-25125 Brescia / IT | Inventor(s) | 01 /
Puricelli, Laura Residing in Via Taramelli, 7 I-25100 Brescia / IT | [1990/36] | Representative(s) | Gervasi, Gemma, et al Notarbartolo & Gervasi S.p.A. Viale Achille Papa, 30 20149 Milano / IT | [N/P] |
Former [1990/36] | Gervasi, Gemma, Dr., et al NOTARBARTOLO & GERVASI Srl Viale Bianca Maria 33 I-20122 Milano / IT | Application number, filing date | 90104069.1 | 02.03.1990 | [1990/36] | Priority number, date | IT19890019637 | 03.03.1989 Original published format: IT 1963789 | [1990/36] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP0385491 | Date: | 05.09.1990 | Language: | EN | [1990/36] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 10.07.1990 | Classification | IPC: | C07D295/088, C07B57/00 | [1990/36] | CPC: |
C07D295/088 (EP)
| Designated contracting states | BE, DE, DK, ES, FR, GB, GR, IT, LU, NL [1990/36] | Title | German: | Optisch aktives Isomer von Cloperastin, das eine hustenstillende Wirkung besitzt, ein Verfahren zu seiner Herstellung und dieses enthaltende pharmazeutische Zusammensetzungen | [1990/36] | English: | Optically active isomer of cloperastine possessing antitussive activity, a process for its preparation and pharmaceutical compositions which contain it | [1990/36] | French: | Isomère optiquement actif de clopérastine qui possède une activité antitussive, son procédé de préparation et composition pharmaceutique qui le contient | [1990/36] | File destroyed: | 03.03.2001 | Examination procedure | 01.03.1991 | Examination requested [1991/22] | 15.06.1993 | Despatch of a communication from the examining division (Time limit: M04) | 01.10.1993 | Reply to a communication from the examining division | 24.03.1994 | Despatch of a communication from the examining division (Time limit: M04) | 07.07.1994 | Reply to a communication from the examining division | 26.01.1995 | Despatch of a communication from the examining division (Time limit: M02) | 10.03.1995 | Reply to a communication from the examining division | 20.04.1995 | Despatch of a communication from the examining division (Time limit: M02) | 01.07.1995 | Application deemed to be withdrawn, date of legal effect [1995/52] | 28.07.1995 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [1995/52] | Fees paid | Renewal fee | 26.02.1992 | Renewal fee patent year 03 | 25.02.1993 | Renewal fee patent year 04 | 28.02.1994 | Renewal fee patent year 05 | Penalty fee | Additional fee for renewal fee | 31.03.1995 | 06   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]GB670622 (PARKE DAVIS & CO); | [A]GB797473 (KONINKLIJKE PHARMA FAB NV); | [A]GB905993 (MCNEILAB INC); | [Y]GB1153436 (YAB SOC [FR]) |